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Jaw morphogenesis depends on the growth of Meckel’s cartilage
during embryogenesis. However, the cell types and signals that
promote chondrocyte proliferation for Meckel’s cartilage growth
are poorly defined. Here we show that neural crest cells (NCCs)
and their derivatives provide an essential source of the vascular
endothelial growth factor (VEGF) to enhance jaw vascularization
and stabilize the major mandibular artery. We further show in
two independent mouse models that blood vessels promote
Meckel’s cartilage extension. Coculture experiments of arterial
tissue with NCCs or chondrocytes demonstrated that NCC-
derived VEGF promotes blood vessel growth and that blood ves-
sels secrete factors to instruct chondrocyte proliferation. Com-
puted tomography and X-ray scans of patients with hemifacial
microsomia also showed that jaw hypoplasia correlates with
mandibular artery dysgenesis. We conclude that cranial NCCs
and their derivatives provide an essential source of VEGF to sup-
port blood vessel growth in the developing jaw, which in turn is
essential for normal chondrocyte proliferation, and therefore jaw
extension.
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Craniofacial abnormalities such as hemifacial microsomia,Treacher Collins syndrome, DiGeorge syndrome, and Golden-
har syndrome arise from developmental deficiencies in the first
pharyngeal arch and are commonly associated with mandibular hy-
poplasia. These disorders are widely believed to result from a
combination of inadequate formation, migration, or differentia-
tion of cranial neural crest cells (NCCs). After delamination from
the neural tube, cranial NCCs migrate into the mandibular pri-
mordia, where they interact with resident epithelium and meso-
derm to initiate differentiation programs enabling formation of
the skeletal components of the jaw (1). Cranial NCCs entering the
mandibular primordia differentiate into prechondrocytes to form
Meckel’s cartilage, which then provides a scaffold for differenti-
ating mandible bone. The proliferation and expansion of chon-
drocytes within Meckel’s cartilage is also the major driving force
behind jaw outgrowth before mandible bone formation (2). Al-
though the signaling processes controlling prechondrocyte dif-
ferentiation are well-established (3, 4), it is unclear which tissue
types and signals instruct chondrocyte proliferation and morpho-
genesis of Meckel’s cartilage.
VEGF (also known as VEGFA) is a secreted signaling pro-
tein that is made in three major isoforms termed VEGF121,
VEGF165, and VEGF189 in humans and VEGF120, VEGF164,
and VEGF188 in mice (5). Notably, mice lacking VEGF164 have
craniofacial defects that include cleft palate, unfused cranial
sutures, and shorter jaws (6). However, the source and precise
role of VEGF in causing these defects have not yet been
established. VEGF is best known for its pleiotropic roles in
vascular development. In addition to supplying nutrients and
oxygen for organ growth and tissue homeostasis, growing blood
vessels also have the capacity to direct tissue morphogenesis. For
example, blood vessels instruct pancreas and liver organogenesis
as well as liver regeneration, and they promote osteogenesis and
osteoblast differentiation during endochondral and intramem-
branous ossification (7–12). VEGF also has direct effects on
nonendothelial cell types such as osteoblasts and osteoclasts and
has been suggested to contribute to chondrocyte survival during
long bone formation (13). Whether VEGF promotes craniofacial
development via roles in blood vessel formation or bone or car-
tilage formation therefore remains to be established. Moreover, it
needs to be investigated whether there is a link between VEGF
and cranial NCC development during the formation of the skel-
etal structures of the face.
Here we show that cranial NCCs and their derivatives provide
an essential source of VEGF to enable vessel growth and arterial
stabilization in the embryonic mandible, and that loss of NCC-
derived VEGF severely impairs chondrocyte proliferation in
Meckel’s cartilage and jaw outgrowth. We further show that in
addition to their general role in supplying oxygen and nutrients,
blood vessels secrete soluble factors that promote chondrocyte
proliferation, explaining the key role of NCC-derived VEGF in
directing mandible growth. Taken together with our finding that
patients with hemifacial microsomia have mandibular artery dys-
genesis that correlates with mandibular hypoplasia, we conclude
that vascular development and jaw morphogenesis are in-
timately linked. Our study therefore provides direct insight
into the mechanisms that regulate jaw development and the
etiology of mandibular hypoplasia.
Significance
Craniofacial development is a complex morphogenic event that
relies on highly orchestrated interactions between multiple cell
types. Since the first description of Meckel’s cartilage in the
lower jaw more than 180 years ago, we have come to realize
that expansion of this specialized structure underpins correct
mandible development. Here we demonstrate that an intricate
association between neural crest cells and blood vessels plays
an important role in promoting chondrocyte proliferation and
expansion of Meckel’s cartilage as a prerequisite of correct man-
dibular morphogenesis. These findings provide direct insight
into the origins and potential treatments of highly prevalent
disorders affecting the mandible.
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Results
Mice Lacking VEGF in NCC-Derived Tissue Have Mandibular Hypoplasia.
To investigate the mechanisms and cell types through which VEGF
controls craniofacial development, we removed VEGF specifically
in NCCs and NCC-derived tissue by crossing a floxed Vegfa allele
with a Wnt1-Cre driver. Wnt1-Cre;Vegfafl/fl mutants were born in
the predicted Mendelian ratio but did not survive beyond the day
of birth (Table S1). Compared with control Vegfa+/fl littermates,
embryonic day (E) 17.5 mutants exhibited mild general bone
hypoplasia of the cranium, including cleft palate and reduced
ossification of the premaxillary and frontal bone (Fig. 1A).
Strikingly, mutants displayed severe mandibular hypoplasia, with
a disproportionately smaller mandible and Meckel’s cartilage
relative to the overall size of the skull. Moreover, the mandible
was shorter and misshapen, with a bow-shaped rather than the
extended arrowhead-shaped morphology seen in wild-type lit-
termates (Fig. 1A). These findings show that loss of NCC-derived
VEGF impairs mandible growth during development and raise
the hypothesis that VEGF may have a direct effect on early NCC
development. Prior chick studies have suggested that VEGF is
expressed by surface ectoderm to promote migration of NCCs
into the facial primordia (14); hence, NCC-derived VEGF may
also be required for NCC migration. Staining of control and
mutant Wnt1-Cre;Vegfafl/fl embryos at E8.5 and E9.5 for NCC
markers, including in situ hybridization for Sox10 and immu-
nostaining for SOX9 and p75, did not identify obvious defects in
either NCC specification or immigration into the primordia of
the mandible, also known as pharyngeal arch 1 (pa1) (Fig. S1A).
In further support of this, lineage tracing of NCCs in Wnt1-Cre;
Vegfafl/fl mutants using a R26R-YFP reporter demonstrated that
at E9.5 and E10.5, there was similar NCC density in pa1 (Fig.
S1B). In situ hybridization for Msx1 and Dlx5 (Fig. S1C), which
are downstream targets of the BMP-4 and Endothelin-1/dHAND
signaling cascade (1, 15, 16), indicates patterning and specification
of pa1 was normal in Wnt1-Cre;Vegfafl/fl mutants. TUNEL and
cleaved-Caspase-3 staining at E9.5 and E10.5 also showed no
increase in cell death in Wnt1-Cre;Vegfafl/fl mutants (Fig. S2). To-
gether, these observations suggest that VEGF is not required cell-
autonomously for early NCC development or survival. Therefore,
the defects responsible for mandibular hypoplasia in mice lacking
NCC-derived VEGF likely occur at a developmental point after
NCC specification and migration into pa1.
Loss of VEGF from the NCC Lineage Impairs the Normal Morphogenic
Transformation of Meckel’s Cartilage that Underlies Jaw Growth. To
understand the origin of jaw defects in E17.5 Wnt1-Cre;Vegfafl/fl
mutants, we next performed a detailed analysis of cartilage and
bone formation in the developing jaw of wild-type embryos. The
analysis of cartilage formation revealed that the jaw normally
undergoes a dramatic expansion and shape transformation be-
tween E13.5 and E14.5 (Fig. S3). Specifically, Meckel’s cartilage
transformed from an immature bow-shaped morphology, with
both cartilage arms convex relative to each other, to a mature
arrowhead-type morphology, with the cartilage arms concave
relative to each other. In this mature form, the distal cartilage
tips had flipped from a caudal to a rostral orientation. During
this shape change, the cartilage also doubled in length. At E14.5,
mandible ossification begins and Meckel’s cartilage maintains its
mature transformed shape for the remainder of gestation (Fig.
S3). This growth and morphology transformation marks a pre-
viously undescribed developmental milestone in mandibular
development that is likely a key step in ensuring the correct
growth, shape, and function of the mature jaw.
We next asked whether Wnt1-Cre;Vegfafl/fl mutants had failed
to undergo this shape transformation of the mandible between
E13.5 and E14.5. We observed that the heads ofWnt1-Cre;Vegfafl/fl
mutants at E14.5 were generally smaller than those of their con-
trol littermates, with a disproportionately shorter mandible (Fig.
1B). Ventral views of the jaw showed that the mandible had ex-
tended toward the maxillary extremity in control embryos, thereby
concealing the tongue and oral cavity; however, the tongue and
oral cavity were clearly visible in mutants because of the shorter
jaw (arrows, Fig. 1B). Alcian blue staining of E14.5 heads revealed
dysmorphology of Meckel’s cartilage in mutants, with a failure of
the cartilage arms to transform from a bowed to an arrowhead
morphology, and this was accompanied by a failure of the distal
cartilage tips to flip from a caudal to a rostral orientation (Fig.
1B, arrows in the lower panels). The persistence of this abnormal
mandible morphology from E14.5 to E17.5 (compare Fig. 1A with
Fig. 1B) in embryos that otherwise continued to develop to birth
excluded the possibility of a general developmental delay as the
cause of defective jaw development inWnt1-Cre;Vegfafl/fl mutants.
Neural Crest Cells Are the Major Source of VEGF in the Developing Jaw
and Are Intimately Associated with Blood Vessels. To understand the
role of NCC-derived VEGF in mandible development, we per-
formed Vegfa in situ hybridization on wild-type andWnt1-Cre;Z/EG
reporter mice, which lineage trace all NCCs and their derivatives,
as well as X-gal staining of VegfaLacZ reporter mice (17). At E9.5,
Vegfa was strongly expressed by all NCCs and NCC-derived mes-
enchyme of pa1, as shown by overlapping expression of Vegfa
mRNA and GFP in Wnt1-Cre;Z/EG reporter mice (Fig. S4B).
GFP-positive NCCs began expressing Vegfa immediately on de-
lamination from the neural tube and maintained high expression
while migrating distally into pa1. This NCC-derived mesenchyme
in pa1 was in close association with developing vasculature. Vegfa
was also expressed by the neural tube and epithelial cells of pa1,
which are not NCC-derived (GFP negative) (Fig. S4B, Inset).
Expression of Vegfa was similar at E10.5, but was enriched in the
anterior domain of pa1 (Fig. S4C, arrowheads).
Whole-mount immunostaining of the jaw at E11.5 identified
many vessels in close association with SOX9-positive primordia
of Meckel’s cartilage, including a major blood vessel running
lateral to Meckel’s cartilage (Fig. S5). At E12.5, when the two
cartilage arms had fused, this major blood vessel extended along
the entire length of Meckel’s cartilage into the distal jaw tip (Fig.
S5). At this age, Vegfa was broadly and prominently expressed in
the NCC-derived mesenchyme surrounding the condensing Meckel’s
cartilage compared with weaker expression in the cartilage itself
(Fig. S6 B and C). Consistent with this, immunostaining at E12.5
showed that Meckel’s cartilage was avascular, but surrounded by
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Fig. 1. Mice lacking VEGF in NCC-derived tissue have mandibular hypo-
plasia. (A) Vegfa+/fl (control) and Wnt1-Cre;Vegfafl/fl (mutant) E17.5 skulls
stained with Alizarin red and Alcian blue. bas, basisphenoid; boc, basioccipital;
eo, exoccipital; fb, frontal bone; md, mandible; mk, Meckel’s cartilage; mx,
maxillary; nc, nasal capsule; pal, palatal; pmx, premaxillary; ppmx, palatal pro-
cess maxillary; tym, tympanic. n = 7/7. (B, Upper) Mandibular hypoplasia is ev-
ident in mutant embryos at E14.5 (arrow). (Lower) Meckel’s cartilage has not
extended in mutants (arrow) and is misshapen. n = 5/5. (Scale bar, 400 μm.)
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many small vessels (Fig. S6 B and C). The mandibular artery
coursing along Meckel’s cartilage was surrounded by NCC-
derived cells and associated with an NCC-derived axon bundle
(Fig. S6C).
At E14.5 and E15.5, expression of Vegfa remained lower in
Meckel’s cartilage compared with the surrounding mesen-
chyme (Figs. S7 and S8B). Vegfa expression was particularly
enriched in the NCC-derived mesenchyme surrounding the
distal tip of Meckel’s cartilage, and this tissue was highly vas-
cularized (Fig. S8B). Strikingly, Vegfa expression was enriched
in the smooth muscle coating of the mandibular artery running
lateral to Meckel’s cartilage, which is exclusively of NCC origin
(GFP-positive) (Fig. S8 B and C).
Vegfa in situ hybridization was also performed on Wnt1-Cre;
Vegfafl/fl mutant embryos, which revealed a lack of Vegfa expres-
sion in the NCC-derived mesenchyme of pa1 at E10.5 and in the
mesenchyme surrounding Meckel’s cartilage at E15.5 (Fig. S9),
confirming NCCs as the major source of VEGF in the developing
jaw. Thus, Vegfa expression in jaw mesenchyme and arterial smooth
muscle supports the idea that NCC-derived VEGF functions in a
paracrine fashion to promote vascular development, rather than
acting cell-autonomously to promote the growth of chondrocytes
in Meckel’s cartilage. Together, these observations show that
cranial NCC development is intimately associated with vascular
development and that developing blood vessels are closely asso-
ciated with Meckel’s cartilage during jaw morphogenesis. Sub-
sequent ossification of the mandible bone around Meckel’s
cartilage and its associated neurovascular bundle (Fig. S8C) leads
to the formation of the mandibular and mental foramen through
which the mandibular artery and nerve enter and exit the mature
mandible bone (18).
Vascular Defects in Wnt1-Cre;Vegfafl/fl Mutants Precede Mandibular
Hypoplasia. Because VEGF promotes blood vessel growth, we
next analyzed vascular development in the Wnt1-Cre;Vegfafl/fl man-
dible before the bow-to-arrowhead transformation. Whole-mount
immunostaining of control and Wnt1-Cre;Vegfafl/fl mutant em-
bryos with the vascular marker endomucin identified an obvious
reduction in pa1 vascularization in mutants at E9.5 and E10.5
(Fig. 2A, arrows). Transverse sections through pa1 followed by
quantitation of the endomucin-positive area confirmed a signifi-
cant decrease in vascular density by almost 50% compared with
controls (Fig. 2B). Costaining with the vascular endothelial marker
CD31 and the vascular basement membrane marker collagen IV
did not identify any basement membrane sleeves lacking endo-
thelial cells in the mutant (Fig. S10). This suggests the decreased
vascular density is a result of reduced angiogenesis, and not vessel
regression. These findings demonstrate that VEGF secreted by
NCC-derived mesenchyme is essential to promote normal vessel
growth in the developing mandibular arch.
At E12.5, the gross morphology of the mandible was similar in
mutants and controls (Fig. S11). SOX9 is a master regulator of
chondrogenesis and is expressed in all chondroprogenitors and
differentiated chondrocytes, where it directly promotes expres-
sion of Col2a1 (collagen type II) (19, 20). Immunolabeling for
SOX9, Alcian blue staining, and in situ hybridization for Col2a1
showed similar specification and differentiation of chondrocytes
within Meckel’s cartilage in control and mutant embryos (Fig. 2C
and Figs. S11 and S12). In contrast, immunostaining with CD31
showed that the microvessel density was decreased in the mutant
relative to the control mandible (Fig. 2C). Moreover, the CD31-
positive mandibular artery appeared significantly narrower in mu-
tants compared with in wild-types (Fig. 2C). Loss of the mandibular
artery along the length of Meckel’s cartilage was also evident in
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Fig. 2. Loss of VEGF from NCC-derived tissue reduces vessel density in the mandibular arch and causes regression of the mandibular artery. (A) Whole-mount
imaging of vasculature immunostained with endomucin at E9.5 revealed an aberrant vascular network in pa1 (arrow); ov, otic vesicle. n = 3/3. (B) Frontal
sections identified significantly reduced vascular density in E10.5 mutant embryos, *P < 0.05; n = 4/4. (C) Immunostaining of frontal sections at E12.5 with
CD31, SOX9, and NRP1 and a serial section with Tuj revealed normal specification of Meckel’s cartilage in mutants. NRP1 and Tuj staining showed normal
development of the mandibular nerve. The mandibular vessel (v) was substantially narrower and the microvascular density was reduced in mutants. n = 3/3.
(D) Immunostaining of frontal sections through the mandible at E15.5 with CD31, SMA, and NRP1, and a serial section with CD31 and collagen IV. The
mandibular artery was absent in mutant embryos, whereas the mandibular nerve remained intact. Collagen IV staining in the absence of CD31 staining
indicates vessel regression in mutants (arrowheads). n = 3/3. (Scale bars: A, 200 μm; C and D, 100 μm.).
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whole-mount staining of mutant jaws at E12.5 (Fig. S11). In con-
trast, the mandibular nerve [Tuj (betaIII-tubulin)- and NRP1 (neu-
ropilin 1)-positive] appeared similar in the neurovascular bundle of
mutants and wild-types (Fig. 2C and Fig. S11).
At E15.5, when mandibular hypoplasia was macroscopically
obvious in mutants, the mandibular artery had atrophied, as in-
dicated by loss of both CD31 and smooth muscle actin (SMA)
staining in the area adjacent to the mandibular nerve (Fig. 2D).
Costaining for CD31 and collagen IV identified many basement
membrane sleeves lacking endothelial cells in the mutant, but not
control mandible, suggesting vessel regression (Fig. 2D, arrow-
heads). In contrast, vessels coated primarily by non-NCC-derived
smooth muscle were unaffected in Wnt1-Cre;Vegfafl/fl embryos
(Fig. S13). Together, these observations suggest a selective de-
pendence of the mandibular artery on VEGF secreted from NCC-
derived smooth muscle. In summary, loss of NCC-derived VEGF
impairs jaw vascularization through reduced microvessel forma-
tion and by causing regression of the mandibular artery.
NCC-Derived VEGF Promotes Vessel Growth in Vitro. To provide fur-
ther evidence that NCC-derived VEGF promotes vessel growth,
primary embryonic NCCs and aortic rings from wild-type adult
mice were cocultured in a collagen matrix in medium lacking
VEGF. Under these culture conditions, primary NCCs or the ad-
dition of recombinant VEGF similarly promoted vessel sprouting
from the aortic rings (Fig. 3A and Fig. S14). Addition of soluble
VEGFR1 (sFLT1) to trap secreted VEGF (21) inhibited NCC-
induced vessel sprouting (Fig. 3A), demonstrating that NCCs
secrete VEGF to promote vessel growth. Together with the ob-
servation of reduced mandible vascularization in mutants lacking
NCC-derived VEGF, these findings are consistent with a model
in which NCCs populating pa1 secrete VEGF to ensure the ap-
propriate vascularization of the developing mandibular arch.
Blood Vessels Promote Chondrocyte Proliferation. The findings
described here suggest that NCC-derived VEGF and VEGF-
induced blood vessels are major factors in the transformation of
Meckel’s cartilage that promotes jaw expansion and elongation.
We therefore examined whether reduced mandible growth in
Wnt1-Cre;Vegfafl/fl mutants is preceded by defective cell pro-
liferation or survival in Meckel’s cartilage preceding the man-
dible defect becoming macroscopically obvious. Staining for the
mitosis marker phospho-histone H3 (PHH3) showed that pro-
liferation of chondrocytes was significantly reduced in mutants
by ∼20% and ∼30% at E12.5 and E13.5, respectively, whereas
TUNEL staining did not show altered apoptosis (Fig. 3B and Fig.
S15). This suggests that defective mandible growth is a result of
reduced chondrocyte proliferation, and not excessive cell death.
Reduced cell proliferation in Meckel’s cartilage may have
been caused by the loss of VEGF acting directly on chondrocytes;
in support of this hypothesis, VEGF has been shown to promote
chondrocyte survival during epiphyseal cartilage formation (22,
23). Alternatively, loss of cell proliferation in Meckel’s cartilage
may be a result of the reduction in VEGF-induced blood vessels
that normally promote chondrocyte proliferation. To distinguish
whether VEGF promotes chondrocyte proliferation directly or
indirectly via blood vessels, we cultured the chondrogenic cell line
ATDC5 in the presence or absence of recombinant VEGF and/or
aortic rings and assessed chondrocyte proliferation by immunos-
taining for PHH3. We observed that recombinant VEGF did not
increase chondrocyte proliferation (compare panels labeled “cells
only” and “+VEGF” in Fig. 3C and Fig. S16 for alternate VEGF
isoforms). In contrast, aortic rings were found to induce chon-
drocyte proliferation (Fig. 3C and Fig. S17A). Moreover, condi-
tioned media from cultured aortic rings was also effective in
inducing chondrocyte proliferation (Fig. 3C). These findings
agree with the expression pattern of Vegfa during mandible
development, which shows prominent expression of VEGF in the
vicinity of blood vessels, but not in Meckel’s cartilage, and are
consistent with a role for NCC-derived VEGF in jaw vascular
development, rather than direct effects on chondrocytes in
Meckel’s cartilage. Together, these findings further support the
idea that blood vessels, in addition to providing general trophic
support, also secrete soluble factors that promote Meckel’s carti-
lage proliferation. Indeed, conditioned media from aortic rings also
promoted proliferation of cultured primary Meckel’s cartilage
chondrocytes (Fig. 3D and Fig. S17B).
Mandibular Artery Defects Cause Mandibular Hypoplasia in Tie2-Cre;
Nrp1fl/fl Mice. To provide additional evidence that blood vessels
promote jaw extension, we next examined Tie2-Cre;Nrp1fl/fl mu-
tant mice because they have well-characterized vascular defects
(24) and were reported to display craniofacial defects at low pen-
etrance (25). NRP1 is an isoform-specific receptor for VEGF in
neurons that also promotes VEGF-independent extracellular ma-
trix signaling in endothelial cells to enable central nervous system
angiogenesis (26–28). Moreover, VEGF binding to NRP1 pro-
motes arterial development in the heart and smooth muscle cell
coverage of retinal arteries (29, 30). Tie2-Cre;Nrp1fl/fl mutant mice
therefore present a complementary model to Wnt1-Cre;Vegfafl/fl
mice to validate a role for blood vessels in jaw development.
CD31 immunolabeling of transverse sections through the E13.5
mandible revealed that Tie2-Cre;Nrp1fl/fl mutants did not exhibit
an overall reduction in vascular density in the embryonic jaw
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Fig. 3. NCC-derived VEGF induces vessel growth, and vessels induce chon-
drocyte proliferation. (A) Aortic rings sprout when cocultured with NCCs or
when induced with recombinant human VEGF165. Quantitation of sprout-
ing from five to 10 aortic rings in two independent experiments. ****P <
0.0001; **P < 0.01. (B) Chondrocyte proliferation in Meckel’s cartilage at
E12.5 and E13.5. Data are mean of n = 3 embryos; E12.5, *P = 0.0109; E13.5,
*P = 0.0195. (C) Proliferation of ATDC5 cells cocultured with aortic rings,
with or without VEGF, or treated with aorta conditioned media. Data are
mean of n = 3 experiments. *P < 0.05; **P < 0.01. (D) Proliferation of primary
Meckel’s cartilage chondrocytes when treated with aorta conditioned media.
Data are mean of n = 3 experiments. *P = 0.0178.
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(Fig. 4A). However, the mandibular artery of Tie2-Cre;Nrp1fl/fl
mutants at both E13.5 and E15.5 was significantly narrower and
lacked a smooth muscle coating (Fig. 4A and Fig. S18). Cor-
relating with impaired mandibular artery development, man-
dibular extension was reduced in three of four Tie2-Cre;Nrp1fl/fl
mutants at E15.5 (Fig. 4B, arrows). This defect was milder than
that of Wnt1-Cre;Vegfafl/fl mutants, suggesting a defective man-
dibular artery impairs jaw extension, but also that general vascular
deficiency, as observed inWnt1-Cre;Vegfafl/fl mice, exacerbates jaw
defects. Our findings in two independent mouse models therefore
indicate that defective vascular patterning in the jaw causes
mandibular hypoplasia that can be explained by a role of blood
vessels in promoting chondrocyte proliferation.
Mandibular Hypoplasia Is Linked with Loss of the Mandibular Artery
in Patients with Hemifacial Microsomia. Our findings in mouse
models show that aberrant vessel growth contributes to cranio-
facial jaw defects. In agreement, a prior study suggested that
craniofacial defects correlated with hematoma of the stapedial
artery in thalidomide-treated mouse embryos (31). Moreover,
this previous study also proposed that embryonic vascular insults
can give rise to hemifacial microsomia, a clinical syndrome of
unclear etiology that variably affects the development of the
facial skeleton and soft tissues including the ears, mouth, facial
musculature, and mandible (32). We therefore examined com-
puted tomography and X-ray images of the mandibles from indi-
viduals with severe hemifacial microsomia (clinical classification
skeletal, auricle, and soft tissue score of 3; n = 6). Specifically,
we assessed whether the mental foramen at the distal tip of the
chin was present as it marks the exit point of the mandibular
artery and nerve from the mandible bone. As the clinical phe-
notype is generally restricted to one side of the face in these
patients, the unaffected side provided an internal reference
point for the correlation between vessel and mandibular defects.
In all patients examined, the mental foramen was absent on the
affected side of the mandible, but present on the unaffected side
(Fig. 5A). In addition, the mandibular foramen, through which
the artery enters the mandible, was narrower and mispositioned
on the affected side of the jaw (Fig. 5B). X-ray imaging further
demonstrated that the canal of the artery and nerve extended
through the bone from the mandibular to the mental foramen on
the unaffected side, whereas this canal was narrower and did not
extend the length of the mandible on the affected side (Fig. S19).
Because the artery is established before the onset of ossification
during embryogenesis (18), these observations suggest the man-
dibular artery was absent on the affected side during critical stages
of jaw development in patients with hemifacial microsomia.
Discussion
Mandibular hypoplasia contributes to the pathogenesis and
clinical pathology of many craniofacial disorders. Understanding
the origins of these disorders and the mechanisms controlling
mandible growth are essential to enable the design and imple-
mentation of innovative diagnostics and therapeutics. We have
shown here that NCC-derived VEGF is essential for jaw vascu-
larization to promote chondrocyte proliferation and subsequent
elongation and shape transformation of Meckel’s cartilage.
VEGF is well known for its pleiotropic roles in vessel forma-
tion, and it also promotes the survival and proliferation of var-
ious nonvascular cell types. For example, VEGF has previously
been shown to promote chondrocyte survival before endochon-
dral bone formation (23). In contrast, our study found no evidence
in favor of paracrine or autocrine effects of VEGF on chondrocyte
proliferation or survival in jaw development. Instead, our coculture
experiments suggest that blood vessels, which require VEGF for
their formation, secrete soluble factors that then promote chon-
drocyte proliferation. Consistent with the idea that blood vessels
play an important role in cartilage morphogenesis, we observed
that Wnt1-Cre;Vegfafl/fl mutants have vascular growth and stabili-
zation defects before notable jaw defects, even though the early
formation, migration, and condensation of NCCs into SOX9-
positive cartilage progenitors is unaffected. Moreover, Tie2-
Cre;Nrp1fl/fl mutants with defective arterial stabilization also
had shorter jaws. Taken together, our data therefore fit best
with a model in which NCC-derived VEGF promotes vascular
development in the jaw, with blood vessels being an essential
source of trophic or secreted factors to stimulate chondrocyte
proliferation in Meckel’s cartilage, thereby enabling its growth
and shape transformation (Fig. S20).
Even though NCCs are known to interact with the dorsal aorta
(33) and pharyngeal arch arteries (34) to establish the sympa-
thetic nervous system and promote remodeling of the cardiac
outflow tract, a specific role for NCCs in stimulating angiogenesis
or stabilizing arteries has not previously been described. Our find-
ings that NCC-derived VEGF is essential for vessel growth, and that
VEGF secreted from NCC-derivatives, such as smooth muscle,
promotes arterial stabilization, therefore add to the growing list of
codependencies between NCC and vascular development.
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Fig. 4. Vessel defects correlate with mandibular hypoplasia in Tie2-Cre;
Nrp1fl/fl mutants. (A) Immunostaining of frontal sections through the man-
dible with CD31, SMA, and NRP1 in E13.5 control and Tie2-Cre;Nrp1fl/fl mu-
tant embryos. n, nerve; v, vessel. n = 3/3. (B) Mandibular hypoplasia in E15.5
Tie2-Cre;Nrp1fl/fl mutants and littermate controls. Note reduced extension of
the mandible to the maxillar extremity (arrows). n = 3/4. (Scale bar, 100 μm.)
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Fig. 5. Vessel defects correlate with mandibular hypoplasia in hemifacial
microsomia. (A) Computed tomography image of a 15-y-old male with a
hypoplastic mandible on his left (affected) side. The mental foramen is ab-
sent on the affected side of the jaw. (B) Computed tomography images in-
dicate the mandibular foramen is present on the unaffected side, but is
distinctly smaller in diameter and mispositioned on the affected side. (Scale
bar, 1 cm.)
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Although a primary role of blood vessels is to provide nutrients
and oxygen to support tissue growth, vessels have also been shown
to provide instructive signals for tissue-specific differentiation
programs in the liver, pancreas, and sympathetic nervous system,
and they also regulate liver regeneration and osteogenesis (7–10,
12, 33). Our in vitro findings suggest an additional angiocrine role
for blood vessels as a source of secreted signals for cartilage
proliferation. Such a role for blood vessels has not previously
been documented for cartilage formation, neither during cra-
niofacial morphogenesis nor elsewhere in the body. Our study
therefore extends knowledge of the processes that enable skeletal
development by identifying blood vessels, in addition to their role
in promoting osteoblast differentiation (8, 11, 12), as important
regulators of chondrocyte proliferation. Future studies should
therefore aim at identifying the vessel-derived factors that pro-
mote cartilage growth to provide insight into the molecular
mechanisms of cartilage growth and craniofacial development.
Our finding that defective blood vessel development leads to
mandibular hypoplasia differs from prior studies in mice, which
identified precocious NCC death (i.e., Treacher Collins syndrome)
(35), abnormalities of pharyngeal arch growth (i.e., DiGeorge
syndrome) (36), or aberrant cartilage specification (i.e., Pierre
Robin Sequence) (3) as causes of craniofacial defects. Our model
of developmental vascular deficiency as a cause of craniofacial
birth defects was corroborated by studies in patients with hemi-
facial microsomia. Although we cannot exclude NCC defects in
these patients, the lack of a mental foramen and vascular canal on
the affected side of the jaw in this patient cohort suggests the
mandibular artery was absent during the critical time of jaw ex-
tension when ossification occurred around Meckel’s cartilage.
This identifies vascular defects as an additional causative factor
for craniofacial malformations, and in the future, it will therefore
be important to investigate the prevalence of vascular defects in
patients with hemifacial microsomia and other similar disorders.
We conclude that VEGF expression by NCCs ensures ade-
quate vessel growth and arterial stability in the jaw, and that
vessel-derived factors in the developing jaw enable appropriate
levels of chondrocyte proliferation and morphogenesis of Meckel’s
cartilage as essential prerequisites for normal jaw extension. Our
findings therefore provide insight into the etiology of craniofacial
birth defects and open the field to further studies into the sig-
naling molecules and/or trophic factors that are supplied by blood
vessels to promote cartilage and craniofacial development.
Experimental Procedures
Animals. All experiments were carried out in accordance with ethical guide-
lines of the SA Pathology Animal Ethics Committee and UK Home Office. To
remove VEGF specifically in NCCs, we crossed Wnt1-Cre;Vegfafl/+ males to
Vegfafl/fl females (37, 38). Lineage tracing was performed with Z/EG or R26R-
YFP mice (39, 40). VegfaLacz embryos (17) were used to visualize VEGF ex-
pression with β-galactosidase activity. To remove Nrp1 specifically in blood
vessels, we crossed Tie2-Cremice to Nrp1fl/flmice (24). Additional methods are
described in the SI Experimental Procedures.
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